ICS 2015 Scientific Podium Short Oral Session S5

Speakers
	Wednesday 7th October 2015
	10:30 - 12:00
	210BC
H Hashim Hashim ICS Chair D Duane Hickling ICS Chair
Learning Objectives
To examine novel research findings in the field of Nocturia/Male LUTS. To discuss methodological challenges for conducting research in the field of Nocturia/Male LUTS. To discern the internal and external generalizability of these research results in order to implement changes in research methods or clinical practice within the participant's own setting.

10:30

#31 CLOCK MUTANT MOUSE IS A NOVEL EXPERIMENTAL MODEL FOR NOCTURIA/NOCTURNAL POLYURIA

Presenter: Tatsuya Ihara

Ihara T¹, Kira S¹, Yamagishi T¹, Miyamoto T¹, Sawada N¹, Yoshiyama M¹, Takeda M¹, Nakamura Y², Nakao A²
1. Department of Urology, University of Yamanashi, 2. Department of Immunology, University of Yamanashi
Basic Science, Nocturia, Outcomes Research Methods

10:37

#32 Medical Outcomes Study Sleep Scale (MOS- Sleep Scale) in the detection of Overactive Bladder in Spanish population.

Presenter: Daniel Arumi

Ballestero Beltrán S¹, Rejas J², Angulo J³, Brenes F⁴, Arumi D⁵, Lizarraga I¹
1. Unidad Médica, Pfizer S.L.U., 2. Investigación de Resultados en Salud y Farmacoeconomía, Pfizer S.L.U., 3. Servicio de Urología, Hospital Universitario de Getafe, 4. Centro de Atención Primaria Llefià, Badalona, 5. Unidad Médica, Pfizer Europe
Overactive Bladder, Outcomes Research Methods, Quality of Life (QoL), Nocturia

10:45

#33 Association of nocturia with poor functional outcomes of sleep among a population-based sample of men and women

Presenter: Camille Vaughan

Vaughan C¹, Fung C², Huang A³, Johnson T¹, Markland A⁴
1. Emory University/Atlanta VAMC, 2. Univ of California Los Angeles/Greater LA VAMC, 3. Univ California San Francisco, 4. Univ of Alabama at Birmingham/Birmingham VA
Nocturia, Quality of Life (QoL), Female, Male, Gerontology

10:52

#34 Fesoterodine for the Treatment of Nocturnal Urgency in Patients with Overactive Bladder Syndrome: An Analysis of Responders and Non-Responders

Presenter: Johnathan A Khusid

Khusid J A¹, Weiss J P¹, Carlsson M², Mangan E²
1. SUNY Downstate College of Medicine, 2. Pfizer Inc.
Nocturia, Overactive Bladder, Urgency/Frequency, Incontinence

11:00

#35 A combination therapy with low dose desmopressin and tolterodine improves health-related quality of life in female patients with overactive bladder and nocturnal polyuria

Presenter: Kristian Vinter Juul

Andersson F¹, Raymond K¹, Vinter Juul K¹, Rosen R²
1. Ferring Pharmaceuticals, Kay Fiskers Plads 11 Copenhagen S, Denmark, 2. New England Research Institutes, Inc., Watertown, MA, USA
Nocturia, Quality of Life (QoL), Questionnaire, Female, Clinical Trial

11:07

#36 The examination of nocturnal urination and sympathetic nerve activity in the elderly people by using 24hr uroflowmetr, sleep EEG measurement and urine cathecholamine.

Presenter: Chie Matsushita

Matsushita C¹, Torimoto K², Hirayama A³, Fujimoto K²
1. Tane General Hospital, 2. Nara Medical University, 3. Nara Hospital Kinki University Faculty of Medicine
Nocturia, Voiding Diary, New Devices

11:15

#37 Difference in uroflowmetry measurements between night and day with aging.

Presenter: Toyoharu Kamibeppu

Kamibeppu T¹, Katayama Y¹, Wakeda H¹, Muraoka K², Kamoto T¹
1. Department of Urology, Faculty of Medicine University of MIYAZAKI, 2. Muraoka Clinic of Urology and Internal medicine
Nocturia, Gerontology, Voiding Dysfunction , Urodynamics Equipment

11:22

#38 The correlation between Metabolic markers, LUTS and hypogonadism in Middle aged Men

Presenter: TengKai Yang

Yang T¹
1. Yonghe Cardinal Tien Hospital
Male, Questionnaire, Benign Prostatic Hyperplasia (BPH)

11:30

#39 A temporal difference observed in the effect of dutasteride on reducing prostate volume depends on the degree of intravesical prostatic protrusion in male patients with benign prostatic hyperplasia

Presenter: Takahisa Suzuki

Suzuki T¹, Otsuka A¹, Furuse H¹, Ozono S¹
1. Hamamatsu University School of Medicine
Bladder Outlet Obstruction , Benign Prostatic Hyperplasia (BPH), Male, Retrospective Study

11:37

#40 Dutasteride add-on therapy improves bladder outlet obstruction in patients with benign prostatic enlargement: one-year follow up with urodynamic study

Presenter: Takahisa Suzuki

Suzuki T¹, Otsuka A¹, Furuse H¹, Ozono S¹
1. Hamamatsu University School of Medicine
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Male, Retrospective Study

11:45

#41 Bladder Dysfunction in Men with Lower Urinary Tract Symptoms Refractory to Alpha-blocker Therapy – A Videourodynamic Analysis and the Relationship with Age and Prostatic Volume

Presenter: Shu-Yu Wu

Wu S¹, Kuo H¹
1. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Male, Benign Prostatic Hyperplasia (BPH), Detrusor Overactivity

11:52

#42 Radical prostatectomy restore the detrusor contraction sustainability: using a new pressure flow study parameter

Presenter: Takeya Kitta

Kitta T¹, Mitsui T¹, Kanno Y¹, Chiba H¹, Moriya K¹, Abe T¹, Maruyama S¹, Shinohara N¹
1. Hokkaido University
Urodynamics Techniques, Male, Surgery

Content Visitors (staff only)

Nocturia/Male LUTS

Scientific Podium Short Oral Session S5

Session Schedule

Comments

Chat